Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/10/24 → 30/09/27 |
Collaborative partners
- Vall d'Hebron Research Institute
- D-Sight
Funding
- Ministerio de Ciencia e Innovación (MICINN): €1,120,073.60
Clinical development of RetSit@, a first-in-class neuroprotective drug to treat Early Stages of Diabetic Retinopathy
- Simó Servat, Olga (Principal Investigator)
- Zapata Victori, Miguel Angel (Investigator)
- Maté, Carla (Co-Principal Investigator (external UAB))